IMMUNOGLOBULIN THERAPY IN GUILLAIN-BARRE-SYNDROME IN CHILDREN

Four children with an evolving Guillain-Barre syndrome were treated wi th a five-day course of intravenous immunoglobulin. No patient showed further progression of the condition and all made a rapid and complete recovery with no evidence of relapse over a six- to 24-month follow-u p period. The early use of immunoglobulin in this disorder may prevent further progression of the disease and accelerate short-term recovery , with resulting medical, social and financial implications.